trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Collecting family history can be used as a test to screen or identify clients who might be at an altered risk for developing the same disease.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that collecting family history can be used as a test to screen or identify clients who might be at an altered risk for developing the same disease?

Yes. Collecting family history serves as an established and effective method in clinical risk assessment to screen and identify clients at altered risk for various hereditary and chronic diseases.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The claim is specific, empirical, and testable. Multiple retrieved papers (such as papers 1, 2, 5, 7, and 9) directly demonstrate that family history is used in risk stratification and screening tools to identify individuals at an altered risk for developing specific diseases like cancer. Therefore, the claim is supported by the evidence.

Evidence for · 5
2026
Polygenic risk score models incorporate family history and other factors to refine cancer risk prediction and identify individuals at altered risk.
Get citation
A, T., L, G., A, V., & S, A. (2026). Polygenic risk scores in cancer.. doi.org. https://doi.org/10.1515/medgen-2026-3011

See more details
More for · 4
2026
Family history is recognized as a consistent and valuable marker for risk-stratified early detection and screening of conditions like colorectal cancer.
Get citation
JM, M., L, C., IE, F., M, S., & A, A. (2026). Closing the Diagnostic Gap in Early-Onset Colorectal Cancer: Red-Flag Symptoms, Screening, and Inherited Risk.. doi.org. https://doi.org/10.3390/cancers18172877

2026
Family history is identified as a key noninvasive predictor and influential factor in machine learning risk stratification models for colorectal polyps.
Get citation
Z, Y., J, L., Y, X., Q, L., Y, H., G, Z., & X, Y. (2026). Development of an Interpretable Triage Tool for Colorectal Polyp Risk Stratification Within a Population-Based Screening Program: Machine Learning Approach.. doi.org. https://doi.org/10.2196/89422

2026
Family history assessment influences clinical screening protocols and management decisions, such as identifying patients who may need earlier or more intensive mammography.
Get citation
T, H., S, S., P, P., K, K., EM, G., TBA, V., E, E., S, H., & KK, S. (2026). A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score.. doi.org. https://doi.org/10.1371/journal.pone.0345431

2026
Comprehensive risk assessment models integrate familial factors to provide precise risk profiling and tailored prevention strategies for hereditary diseases.
Get citation
RHE, K., S, D., A, H., J, W., B, A., JR, L., V, S., & J, H. (2026). PRS-BC<sub>313</sub> integration for tailored breast cancer prevention in female patients and their healthy relatives.. doi.org. https://doi.org/10.1136/jmg-2025-111211

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work